All
Effective Strategies for Pediatric Formulation Development
November 17th 2022Thursday, November 17, 2022 at 10 am EDT | 9 am PDT | 6 am CDT In this webcast, panel speakers will discuss the unmet needs within the pediatric population, swallowability challenges related to children’s medications and strategies to optimize pediatric formulation development resulting in improved acceptability and patient treatment plans.
Formulation Technologies for the Development of Dry Powders for Inhalation
November 16th 2022Wednesday, November 16, 2022 at 11 am ET | 8 am PT | 4 pm GMT | 5 pm CET This webinar will discuss challenges and key considerations for spray-dried formulations for inhalation, along with a review of current technologies and approved products utilizing particle engineering approaches.
Spatial Biology: Hype or Hope?
November 15th 2022Tuesday, November 15th, 2022 at 10 am EDT | 8 am CDT | 7 am PD Spatial Biology is changing the drug development landscape. Validating efficacy with and actual image of the molecule interacting with the tissue provides the additional data needed to determine success or failure. Join the webinar on November 15th to learn more about the solutions Spatial Biology provides.
MOBILIZE YOUR DATA. MODERNIZE YOUR LAB.
October 27th 2022Thursday October 27, 2022 at 11am ET | 10am CT | 8am PT When it comes to freely accessing and sharing lab data, there’s a lot working against you out there. To create infrastructure that truly mobilizes your data and modernizes your lab, you need a new kind of solution.
Everything you need to know about hybrid/decentralized trials
October 20th 2022Thursday, October 20, 2022 at 11 AM EDT | 10 AM CDT | 8 AM PDT It’s no secret that hybrid and decentralized trials (DCT) are here to stay. Make sure your organization is ready for the shift towards clinical trials that put patients first.
Chemically Modified mRNA as a Biologic: Developing an Analytical Framework for Success
October 5th 2022Wednesday, October 5, 2022 at 11:30am ET | 10:30am CT | 9:30am PT Developing an Analytical Framework for Success using a chemically modified mRNA can be compared with those for traditional biologics,. As such, it’s especially important that control on quality and consistency is maintained to ensure well characterized drug substance.
Developing Liquid Formulations for the Oral Dosing of Lipophilic Drugs
October 4th 2022Tuesday, October 4, 2022 at 11am CDT |12pm EDT | 9am PDT Is developing formulations of highly lipophilic compounds worth the effort? With today’s excipients and technologies, the answer is a definite yes. This presentation will showcase the issues presented by lipophilic compounds and ways to address them.